While the magnitude of reduction in GIP tended to be higher in patients receiving AN-PEP (47.6%) vs placebo (44.1%), this difference did not reach statistical significance.
← all excerpts
Effect of <i>Aspergillus niger</i> prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet.
1
—
—